Research Paper Volume 13, Issue 23 pp 25466—25483
Prognostic value of CDCA3 in kidney renal papillary cell carcinoma
Figure 1. Overexpression of CDCA3 in patients with KIRP. (A) CDCA3 expression in normal samples from the GTEx database and the TCGA and 33 tumor samples in TCGA. ns, p ≥ 0.05; *, p < 0.05; **, p< 0.01; ***, p < 0.001. (B) CDCA3 expression in 33 tumor samples in TCGA and paired paracancerous tissues in TCGA. ns, p ≥ 0.05; *, p < 0.05; **, p < 0.01; ***, p < 0.001. (C) CDCA3 mRNA expression level in 288 KIRP samples and 32 normal samples. *** p < 0.001. (D) CDCA3 mRNA expression in KIRP tissues and in paired paracancerous normal samples. *** p < 0.001. (E) CDCA3 mRNA expression in normal samples and KIRP from the GTEx database and TCGA. *** p < 0.001.